Breztri Aerosphere™ (budesonide/glycopyrrolate/formoterol) – New drug approval
July 24, 2020 - AstraZeneca announced the FDA approval of Breztri Aerosphere (budesonide/glycopyrrolate/formoterol), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Download PDF
